According to Sun et al., the expression of MLK1, MLK2, and MLK4 was significantly downregulated in glioma (comprising glioblastoma, anaplastic astrocytoma, and oligodendroglioma) compared to normal brain tissues. The gene discussed is MAP3K9; the disease is central nervous system cancer.